Ma Yinglong: The subsidiary transfers the equity of its controlled subsidiary

2026-04-03 06:58:21

Mayinglong’s announcement: The company’s controlling subsidiary, Mayinglong Medical Management, plans to transfer its share of contribution in Beijing Medical Management of 61.058 million yuan (79.8144% of Beijing Medical Management’s registered capital) to Zhuozhun Technology at a transaction price of 104 million yuan. The expected impact of this transaction on the net profit attributable to the company’s shareholders listed on the stock exchange is 69.7195 million yuan; the final impact amount shall be based on the data audited by an accounting firm.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.